Disposition of 200000 shares by Mcnulty Brian Patrick of MIRA Pharmaceuticals, at 1.96 subject to Rule 16b-3

Read at macroaxis.com

Published over three months ago View all stories for MIRA Pharmaceuticals, | MIRA Pharmaceuticals, Hype Analysis

Disposition of 200000 common stock at 1.96 of MIRA Pharmaceuticals, by Mcnulty Brian Patrick on 28th of August 2024. This event was filed by MIRA Pharmaceuticals, Common with SEC on 2024-08-28. Statement of changes in beneficial ownership - SEC Form 4

Cash Flow Correlation

MIRA Pharmaceuticals,'s cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the MIRA Pharmaceuticals,'s relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.

We analyze MIRA Pharmaceuticals,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MIRA Pharmaceuticals, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MIRA Pharmaceuticals, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with MIRA Pharmaceuticals, stock to make a market-neutral strategy. Peer analysis of MIRA Pharmaceuticals, could also be used in its relative valuation, which is a method of valuing MIRA Pharmaceuticals, by comparing valuation metrics with similar companies.

When running MIRA Pharmaceuticals,'s price analysis, check to measure MIRA Pharmaceuticals,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MIRA Pharmaceuticals, is operating at the current time. Most of MIRA Pharmaceuticals,'s value examination focuses on studying past and present price action to predict the probability of MIRA Pharmaceuticals,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MIRA Pharmaceuticals,'s price. Additionally, you may evaluate how the addition of MIRA Pharmaceuticals, to your portfolios can decrease your overall portfolio volatility.